Most of the focus of this blog is generally on the pharmaceutical side of the business related to cold chain, supply chain and the management of temperature controlled drug related products.
Reading many of the latest comments and articles from the EU it appears that compliance audits have already started in earnest by the regulatory authorities now that the implementation period is well over (6 months from March 2013).
Last Wednesday (March 12th) we held our webinar related to new and global supply chain regulations and Risk Assessment and Risk Planning. This webinar was well attended and the majority of those individuals that had registered did attend and listened to the webinar.
In a recent Blog post I discussed two recent regulations that were introduced last year, one for GDP (Good Distribution Practices) within the EU and one for GSP (Good Supply Practices) within China.
On November 27th of 2013 when President Obama signed into law the HR3204 - the Drug Quality and Security Act, it was the result of many years of discussion and past attempts to establish a US centric law based upon securing the drug supply chain in an effort to prevent the entry of falsified medicinal products into the supply chain.
Page 5 of 6